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Nodular Excision of Prostatic Carcinoma
Experience w i t h Four Patients
E. E. Steinhardt, M . D . * and A . W . Bohne, M . D . *

It is well-known that carcinoma of
the prostate grows slowly for many
years, remaining relatively innocuous
for a long period. Predicting the lethal
potential of the cancerous prostatic
nodule is therefore uncertain.
In certain situations, because of this
slow growth, it may be possible to consider a somewhat less radical treatment than total removal of the gland.
The four cases reported here illustrate
these special circumstances—and the
technique used.
Our procedure of nodular excision
may be appropriate under the following
conditions:
1. When the radical operative procedure is not technically feasible for
one reason or the other.
2. When the pathological diagnosis
on the frozen section is equivocal.
3. When the age and desires of the
patient makes the preservation of potency and continence highly desirable.
Background—Prognosis
Gleason's classification^ of the microscopic cell pattern in prostatic car-

cinoma gives us as accurate a prognosis
from the microscopic slide as the urologist can get from the clinical, laboratory and x-ray findings. After classifying the degree of differentiation of
prostatic carcinoma into five patterns,
he combined these patterns with tumor
staging and developed a much improved index for prognosis.
On the other hand, Jewett et alhave been unable to demonstrate the
potential biological activity of a cancerous prostatic nodule by any routine
histologic technique. Some nodules of
low grade cancer grow rapidly and
metastasize early; others are dormant
for years. In Jewett's series of 86 patients with locally limited prostatic
cancer, one third lived 15 years free
of the disease after undergoing radical
perineal prostatectomy. This was twice
the cure rate of those given endocrine
treatment.
The well-documented reports of the
Veterans Administration Cooperative
Urological Research Group''-** showed
that the median survival time for the
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3,100 patients studied was 31/2 years.
The most important factor in determining the prognosis in these patients
was the high mortality rate from unrelated diseases; 67% of the deaths
were from intercurrent diseases.
Barnes' showed that "the 15-year
survival of patients with early prostatic
carcinoma, who were treated conservatively, is almost the same as it is in
similar cases treated by total prostatectomy". The average age of his patients was 66 years.
As Watson**' and other investigators'"- " have reported, the prognosis is
better in older patients, for whom prostatic cancer seems less lethal.
A finding of perineural invasion
seems to have little influence on the
outcome. Roden et aP- demonstrated
that the so-cafled perineural lymphatics
have no endothelial lining, and that
no lymphatics could be seen in the
perineurium with the electron microscope. They concluded that cancer
spreads along the nerves in the prostate,
within the tissue planes of least resistance, and not in lymphatics.
In the Veterans Research Group,
patients who were given estrogens following radical prostatectomy for Stage
I and Stage I I carcinoma had a lower
survival rate than those who were given
postoperative placebos. Estrogen therapy increased the risk of death from
cardiac and cerebrovascular causes.

was electrosurgically excised widely. Surrounding tissue was excised and submitted
separately for microscopic examination. The
base was then fulgurated.
In one 61-year-old patient, the pathologist
reported a well differentiated small gland
type of adenocarcinoma surrounded by normal tissue. In another 61-yearold man, the
report showed focal nodular areas of adenocarcinoma with perineural lymphatic invasion. In this patient, sections from surrounding prostatic tissue were normal.
Frozen sections from the third patient, 55
years old, were indeterminate. The permanent sections later showed round atypical cells
with perineural invasion extending to the
resected edge of the specimen.
In the fourth patient, 56 years old, the
frozen sections showed no evidence of carcinoma. Permanent sections showed adenocarcinomas without perineural invasion.

Our patients averaged 12 days' stay
postoperatively, with an uneventful
postoperative course except for a mild
urinary tract infection in one patient.
All patients were continent and potent.
These four patients have been followed
for periods up to nine years and are
asymptomatic with no treatment other
than that described. They did not receive hormones or irradiation therapy,
nor was an orchiectomy performed.
Current physical examinations on afl
four show a benign smooth gland.
Laboratory studies are normal.
We do not suggest that nodular excision of prostatic carcinoma as practiced
by us is an equivalent substitute for
radical prostatectomy. The best method
for a possible cure still seems to be
total surgical removal of the prostate,
as originally practiced by Young, later
modified by Hudson and Belt, and the
procedure developed by Miflin and
others.-' '--'^ The authors' experience
with radical prostatectomy in other
patients is similar to theirs.
Summary
Four patients, 50 to 70 years of
age, each with a solitary prostatic nod-

Four Case Histories
Four patients between the ages of 50 and
70 years were presented for evaluation and
treatment of solitary prostatic nodule. All
were essentially asymptomatic, and preoperative studies showed no clinical, biochemical or radiological evidence of extension. They were all classified as Stage I
with nodules measuring 0.5 cm, 0.7 cm, 1
cm, and 1.1 cm, respectively.
After open perineal biopsy, the nodule
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ule but otherwise asymptomatic, were
referred for evaluation and treatment.
Preoperative studies showed no clinical,
biochemical or radiological evidence of
extension. They were classified as belonging in Stage I . All underwent open
perineal biopsy. At surgery, for one
reason or another, a radical prostatectomy was not done. In some, frozen

tissue diagnosis was equivocal and permanent sections later showed definite
adenocarcinoma. When radical procedure was not indicated, or could not
be completed, the nodule was electrosurgically excised and the base fulgurated. After nine years of followup,
these patients show no evidence of
recurrence and are asymptomatic.
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